/Danaher%20Corp_%20logo%20on%20phone-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
Washington, D.C.-based Danaher Corporation (DHR) designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States and internationally. With a market cap of $135.3 billion, the company operates through Biotechnology, Life Sciences, and Diagnostics segments.
Companies worth $10 billion or more are generally described as "large-cap stocks." Danaher fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the diagnostics and research industry. Its wide range of offerings includes bioprocessing technologies, genomic medicines, clinical instruments, consumables, software, and services, which gives it a competitive edge over its peers.